Kit Vaughan

Kit Vaughan’s experience over the past three decades includes a post-doctoral fellowship in orthopaedic engineering at Oxford University, a tenured professorship at the University of Virginia, and 14 years as the Hyman Goldberg Chair in Biomedical Engineering at the University of Cape Town (UCT). During this latter period he helped to pioneer the medical device industry in South Africa, contributing to Disa Vascular, Acorn Technologies, Lodox Systems, the Leatt Corporation, and Strait Access Technologies. Kit is a Fellow of the International Academy for Medical and Biological Engineering, and his qualifications include a BSc (Honours) in applied mathematics and physics (Rhodes), a PhD in musculoskeletal biomechanics (Iowa) and a DSc (Med) in biomedical engineering (UCT). Since 2010 Kit has served as the Chief Executive Officer of CapeRay Medical (Pty) Ltd, a company that has developed, clinically tested and commercialised a novel dual-modality system for the early detection of breast cancer.